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1. Introduction
Deviation from an acceptable standard of care is one of the central issues in a lawyer’s mind
in any malpractice lawsuit. However, the trigger for a lawsuit is the occurrence of a compli‐
cation. That is, intense scrutiny of a doctor’ practice usually only occurs once harm has occurred
to a patient.
Thus avoiding complications is the maxim to follow. Understanding the situations in which
complications leading to law suits may arise is most important.
Not all complications will lead to law suits depending on how they are handled and, for
example non negligent complications and side-effects may be successfully defended if
appropriately consented.
The trend towards more accreditation may reduce rare but serious complications. Many
Boards (in the USA) and Faculty of Pain Medicine (in the UK) amongst others and international
organizations such as World Institute of Pain (WIP) have introduced standards of training in
an attempt to reduce complications rates.
If you are sued, remember no one is going to care more about the result than you do. Pick the
best lawyer and experts to defend you.
2. Principles that may help avoid lawsuits
2.1. Physician attitude towards patients
There is evidence that avoiding distressed or angry patients are associated with better
outcomes and fewer complaints and lower rates of litigation [1]. Always be respectful and
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pleasant with patients and communicate with them, this leads to lower rates of complaints
and litigation. Patients are treated in private but you practice in public, in front of a jury of
your peers [2-5].
2.2. Minimizing errors during conduct of interventional procedures
Steps to promote safety for interventional pain procedures include the “time out” where
activity stops and the team of the patient, nurses and physicians verify the patient’s identity,
the diagnosis, the procedure, the side of the procedure (right or left), a valid consent form,
allergies and other critical information before proceeding with the procedure. Labeling
syringes and marking the site of the procedure is also helpful. Numerous deaths have occurred
from erroneous labeling and administering the wrong drug.
Performing the correct procedure for a specific pain problem is more important than perform‐
ing an alternative procedure first because it may be less expensive.
The practice of performing series of procedures and the use of algorithms of multiple proce‐
dures is non-specific and needs to be refined to be not only more cost effective but to reduce
risk.
The use of physician extenders is a risk factor for medical-legal disputes in pain management.
Physician standards of care are the standard that patients expect and the evolving practice of
pain management does not lend itself well for delegation of decision making for opioid
prescribing and procedure selection [6].
Monitoring the patient, having venous access and having equipment for anaphylactic reactions
and other emergencies is advisable for procedures other than simple peripheral injections.
2.3. The increasing use of anticoagulation
Anticoagulation has become very common in the United States, as has daily aspirin therapy.
The management of these medications before and after pain management procedures is
problematic since existing data does not answer all questions. Discontinuing aspirin has been
associated with stroke and myocardial infarction; however, new platelet function tests are
markedly abnormal with one 325 mg tablet per day. Patients with mechanical valves or recent
coronary stints or pulmonary emboli are not good candidates for discontinuing anticoagula‐
tion. Coordination with the anticoagulant managing physicians is important when these
patients need procedures.
Discontinuing platelet inhibitors has more advocates than opponents but the risk of bleeding
versus infarction is a subject that is well suited for a discussion with the patient’s other
physicians and with the patient.
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3. Medical malpractice
Medical legal issues may arise in the form of a lawsuit, brought by a patient or their represen‐
tative or from a hostile action from a licensing agency, a hospital privilege committee, a medical
society, an insurance company or government health plan, a certifying board or other gov‐
ernment agency or non-government party.
3.1. Four conditions constitute a malpractice claim
1. A duty must exit between a physician and the patient. In other words, a doctor –patient
relationship must exist.
2. the duty must have been compromised by negligence.
3. the patient must have suffered damages.
4. the alleged negligence must be proven to have caused the damages.
3.1.1. Related to the above concepts is the burden of proof test
In order to bring a successful claim against you, the patient, or other person bringing the claim,
has to prove on the balance of probabilities:
Breach of duty – that the treatment was such that no reasonable practitioner would have
delivered that care
3.1.2. Causation and negligence
Causation – that the breach of duty or negligence caused or contributed to the injury, loss or
damage suffered, and that the patient would not have suffered that injury without the breach
Causation, or proof that damages resulted from negligence and were not coincidental, has a
threshold of being more likely that not, other wise know as the 50.1% test
Both these tests have to be established to prove negligence [7].
Negligence, or a breech of duty, is a deviation from the standard of care. Standard care is the
care provided by a reasonable and prudent physician of the same specialty and under the same
circumstances, otherwise known as the Bolam test [8].
3.2. Effects of medical malpractice of healthcare delivery
Physicians claim that medical malpractice liability increases healthcare costs and limit access
to care for which there is now increasing evidence [9]. There is some evidence that practicing
“defensive medicine” probably worsen outcomes.for patients [10].
Advocates of the medical malpractice system argue that malpractice insurance premiums are
a result of poor insurance company management. The Harvard Medical Practice Study in 1990
reposted that only a small fraction of patients with negligent injuries sued and that more suits
were in order rather than less.
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3.3. Tort and it’s reform
A tort is a civil wrong that causes injury, exclusive of a breach of contract. Medical malpractice
is a tort resulting from negligence, which is defined as conduct that falls below the standard
established by law for the protection of others against unreasonable risk of harm. An inten‐
tional tort may arise when informed consent is not obtained.
Tort reform initiatives have proposed several ways to reduce the costs of malpractice awards.
[11, 12]
Caps on noneconomic damages limit the amount of money that can be awarded for pain and
suffering. Some jurisdictions have limits of $250,000. Economic damages cover medical
expenses, lost wages and costs of re-education and/or rehabilitation.
Caps on punitive damages limit the amount of money awarded for conduct that is beyond
negligence and includes fraud or evil. Advocates for caps have argued that evidence must be
“clear and convincing” rather than “a preponderance” before punitive damages are awarded
[13]. It has been argued that a portion of punitive damages go to a fund for a public purpose
rather than to the plaintiff.
Abolishing joint and several liability would prevent each defendant from being liable for 100%
of the damages. The principle of joint a several liability serves to assign liability equally to all
defendants rather than allow defendants to divide responsibility based on their portion of
conduct.
The collateral source rule allows plaintiffs to be compensated twice for the same injury.
Abolishing this rule would result in an offset of damages based on other resources such as
insurance payments and disability payments [14].
Contingency fee limits would require attorneys to be paid based on the amount of work they
perform rather than a percentage of the awarded damages but in other jurisdictions such as
the UK there are imperatives which state the costs in a case must be proportionate [15]
Statues of limitations require malpractice lawsuits to be filed within a time period from the
injury. In the UK this is generally accepted to be 3 years in most circumstances [16]. If an injury
is not discovered immediately or of the injured person is a child, the limitation is frequently
expanded to allow a suit to be brought. A newborn baby is obviously unable to file a lawsuit
but can when adulthood is reached. In the UK the statute of limitation only starts when the
child reaches 18 [17] Medical records tend to degrade after years and memory is of limited
help. These factors disadvantage the defense of a physician though the advent of electronic
records may prove helpful in this respect.
4. The American society of anesthesiologists closed claims study
The ASA closed claim study has resulted in a number of reports regarding pain management
and related liability. The number of claims against anesthesiologists for pain management
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doubled between 1985 and 1989. It doubled again between 1990 and 1994 [18]. Claims for
postoperative pain management increased from 6% during the 1980’s to 8% in 2000 [19].Claims
from chronic pain management increased from 7% between 1985-1994 to 12% between
1995-2004. [20]
In a large report, the number of claims increased since the 1980’s before pain management
began to grow as a specialty. Deaths from epidural injections were associated with epidural
injection of local anesthetic and opioid. Nerve damage and pneumothorax were reported to
be most common causes of claims. Intra-thecal pump mishaps were also associated with
deaths. [21]
44% of medication errors have been related to incorrect dosing, 30% are related to wrong drug
administration, 10% are related to contraindicated drugs and 8% are related to incorrect timing
of administration. [22]
Most medication claims are associated with medication misuse and both patient and physician
conduct contribute to a high proportion of deaths.
Medication management claims were associated with men with back pain who were prescri‐
bed long acting opioids and also taking other psychoactive medications and had signs of
medication misuse. [23]
Blocks accounted for 84% of claims during the 1990s. [24]
50% of nerve injury claims involved spinal cord injury. Pneumothorax from trigger point
injections has been a common claim. [25]
Spinal cord injuries have been reported to be associated with cervical procedures in women
under general anesthesia. [26]
22% of chronic pain claims are related to cervical procedures and the injuries are commonly
permanent and disabling.
Brain damage and death were associated with epidural steroid injection only when used with
local anesthetic or opioid [21].
Ultrasound guided nerve blocks have been associated with fewer claims [27].
Other factors have been reported as a part of the closed claim study.
Agreement among experts in malpractice cases has been shown to correlate poorly. (k 0.37] [28]
However, publishing and publicizing examples of questionable expert testimony has been
discouraged for legal reasons. [29]
Malpractice insurance rates vary widely from $15,000 to $64,000 per year depending on the
states’ legal system and award amounts over time [30].
The recommended amount of malpractice insurance coverage varies but 1-3 million dollars
per claim and 3-6 million dollars in aggregate have been proposed [31].
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The closed claims study data is limited statistically because it reports the numerator but not a
denominator, so trending is difficult to evaluate. However, it clearly serves a good purpose in
identifying potential problems.
The closed claims study does not include information from non-anesthesiologists and pain
management has become a multi-specialty field with a variety of specialists performing
procedures oftentimes with little training.
In the State of Georgia, one malpractice insurance carrier no longer offers coverage for
physiatrists who perform trigger point injections because of the high rate of pneumothorax.
The use of a 25 or 30 gauge needle and fanning injections is associated with pneumothorax.
Fanning injections with a small gauge needle tends to produce multiple punctures along the
same track rather than injecting in multiple directions as intended with the fanning motion.
The reason is that the small gauge needle lacks the stiffness necessary to overcome the “grip”
of the muscle and has a “woodpecker effect” producing multiple punctures of the pleura. Using
22 gauge needles for trigger point injections or avoiding fanning, we have not seen this
problem.
5. Some complications and their mechanisms
25 plus years of serving as an expert in 350-400 cases (GBR) as well taking into account the UK
perspective (RM) has revealed some patterns of complications and likely mechanisms. Many
cases settle and no record of the complication is made and valuable information is lost. The
following section represents some of that information.
With increasing emphasis on treatment of pain, there has been recognition of recurring
patterns of complications. Therefore once understanding reaches a broad base of practicing
clinicians, a reduction of these serious but rare complications should be possible.
5.1. Pneumothroax
Pneumothorax is a complication for trigger point injections. Frequently the needle used was
25 G or smaller. These needles bend easily and when “fanning” injections are made, the needle
tract is uncontrollable. A “woodpecker” effect can result with multiple holes in the pleura and
a pneumothorax requiring a chest tube is a common trigger for a lawsuit. Medicare will no
longer pay for treatment of a pneumothorax from a central line placement and similar
reimbursement patterns may be forthcoming for pain related complications.
5.2. Injections near the cranium
This same mechanism can occur with other injections. For example, injecting a painful scalp
scar after craniectomy for acoustic neuroma has resulted in local anesthetic being injected
intracranially.
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5.3. Cervical sympathethetic injections
Cervical nerve root injection occurs after cervical sympathetic (stellate ganglion) block using
the classic technique. Needles directed to Chassignac’s tubercle are directed to the vertebral
artery and cervical nerve root. Local anesthetic injection may result in immediate seizures or
paralysis but delayed complications may result from subdural blocks after patients have been
discharged. Patients should be monitored for longer periods of time in an environment with
full resuscitative personnel and equipment. A lesson learned from this is that the needle tip
migrates into a nerve or artery where injection occurs. The new Bella D needle (Epimed,
International) has a sealed tip and a side port for directional injection, and may reduce this
occurrence.
5.4. Spinal transformainal injections and the erroneous concept of a “safe” area for injection
Deaths after transforaminal injections have occurred and the notion of a “safe” avascular area
in the posterior foramen has been shown to be false. Local anesthetic injection or arterial injury
can result in catastrophic spinal cord injury and/ or death. Huntoon has demonstrated arterial
supply in each posterior cervical neuroforamina which effectively discredits the concept of a
safe area [32]. The increasing number of cases of catastrophic neurological injury in the lumbar
region following otherwise supposedly correct injection appropriate have also undermined
the concept of this “safe” area and an alternative site; Kambins triangle has been alternatively
proposed [33] [34].
Unfortunately catastrophic has occurred following injection of saline, contrast and steroid and
is not prevented by digital subtraction angiography [35] The onset of neurological signs may
be delayed and may be associated with the lack any obvious untoward effects at the time of a
test dose of local anesthetic which was used to confirm epidural placement. The authors
suggested Utilizing blunt needles or larger bevel needles in place of sharp, cutting needles
may minimize the chances of this event occurring. Subdural injections may also be associated
causes vasospasm and infarction.
5.5. The debate over sharp versus blunt needles
Sharp needles by their very design minimize the feedback produced as bodily structures are
penetrated. This means there will be minimal awareness of vascular, neural and spinal cord
structure with needle advancement. Such injections seem to be associated with more lawsuits.
The dural can be more easily punctured and local anesthetic and corticosteroid preparations
can be injected.
Despite the fact no randomized controlled data exist for sharp needle injection safety, serious
concerns have been raised. Sharp needle movement after initial placement seems to be a factor
as well. In response The Bella D needle has been designed in an attempt to reduce punctures
and migration associated with small movements. The tip is blunt and a side port is located
proximal to the tip. Blunt needles have been shown to be less likely to puncture nerves and
arteries in animal studies [36]. Interscalene block complications have also been associated with
sharp needles. Intra-cord injections, quadriplegia, Brown-Sequard and brachial plexopathy
Medico-legal Aspects of Pain Medicine
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have been reported. The true incidence of major complications is unknown. Sweet reported
one death and several hematomas in a series of 7000 foramen ovale procedures. This may be
a similar complication rate for pain procedures
The RX-2 coude (Epimed International) epidural needle has a second stylet, which is blunt to
convert the needle tip from sharp to blunt to reduce the incidence of a dural or venous
laceration when rotating the needle in the epidural space. The second stylet is placed once the
epidural space is reached but before any rotation. The blunt tip stylet projects 1mm beyond
the tip of the needle and acts as a guard to the sharp edge of the needle.
The RX-2 coude needle is gaining wider acceptance for epidural needle and catheter place‐
ments as well as spinal cord stimulation electrode placements.
A lesson learned is that every case of spinal cord injury and death until has been associated
with the use of sharp needles by direct trauma or the mechanism of arterial penetration and
comprise of the arterial supply. Experimental studies suggest that blunt needles have not been
associated with arterial wall penetration [36].
The available clinical information and animal data supporting the use of blunt needles only
applies to blunt needles and cannot be extrapolated to pencil point tip needles. Pencil point
tip needles are designed to penetrate the dura and have not been studied with regard to
puncturing arteries and nerves.
The pencil tip needles have not been studied regarding perforation into nerves or arteries. The
blunt needles have been shown not to perforate from 18 gauge to 25 gauge.
The disastrous vascular and neurological complication seen with stellate ganglion procedure
should theoretically be avoidable using the Bella D needle. Most of these complications seem
to be related to the classic C 6 approach to Chassaignac’s tubercle. The teaching to make bony
contact and then pull back 1mm is an inexact process and the needle tip and injection can be
placed in an artery or nerve. Cases of immediate or delayed total spinal block, brain or spinal
cord infarction have occurred. Using the Bella D needle placed at the lateral body of C7 may
reduce the incidence of these complications.
Whilst some of the evidence does suggest blunt needles may be safer, the first cases of spinal
cord injury the use of blunt needles are now being reported to be associated with vascular
spread [37]
The curved, blunt RF (Racz-Finch) needle is being used increasingly in an attempt to avoid
intraneural, intracord and intra-arterial placement especially with the use of particulate
corticosteroids. Thus far, no cases involving these needles have surfaced.
The curved blunt needle must be used with an introducer but once it is placed, it can be used
as a percutaneous navigation devise (PND) and directed around other structures to the target
area.
This same concept is behind the Rx 2 coude and the 14-gauge spinal cord stimulation electrode
epidural needle, which can be used to steer the electrode safer and in less time.
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5.6. Particulate steroids
Patients with acute and chronic pain have received steroids in neuraxial blockade for many
years. There has been recent controversy about their efficacy but also about the possibility of
neurological complications associated with the use of particulate steroids such as methyl‐
prednisolone, triamcinolone and betamethasone. In contrast dexamethasone is a non-partic‐
ulate steroid with less platelet aggregating properties [38].
Scanlon et al reported that in the USA between 1998 and 2003, the number of cervical and
thoracic TF ESI almost doubled. They noted at the time of writing 27 cases of brain and spinal
cord infarction following TF ESI and their survey revealed a further additional 78 cases
following a survey of 1400 or so physicians despite a response rate of approximately only 21%.
In no case was the use of non-particulate steroid dexamethasone associated with adverse
neurological outcomes. Depomedrone, a particulate steroid was 7 times more likely to have
been used in cases where there was evidence of brain and spinal cord infarction than either
triamcinalone or betamethasone. No cases were reported with dexamthasone. However it
could be argued this simply reflected a frequency of use rather than a propensity to cause
problems.
In particular it was hypothesized inadvertent intra-arterial injections of particulate steroids is
thought to lead to spinal cord ischaemia by blocking of small arterioles and secondary
catastrophic neurological and other complications and indeed studies showed that methyl
prednisolone and triamcinolone were more likely to aggregate than dexamethsone or beta‐
methasone, sometimes up to 100um in diameter on microscopic slides which have the
theoretical ability to block small arteries [39]. [40] [41] [42].
Use of contrast and aspiration is no guarantee that vascular uptake has not or will not take
place. The overall incidence of intravascular uptake during lumbar spinal injection procedures
as determined by contrast enhanced fluoroscopic observation is 8.5%. Preinjection aspiration
failed to produce a flashback of blood in 74% of cases that proved to be intravascular upon
injection of contrast dye [43] Despite this evidence, a survey in 2012 suggested a significant
proportion of UK pain consultants continued to use particulate steroids for cervical injections
and even greater proportion for lumbar root injections [44]. A clinical negligence barrister in
the UK has commented the current position of UK pain consultants who continue to use
particulate steroids is uncertain in terms of breach of duty if they haven’t offered patients the
probably safer option of non particulate steroids even if they continue not to accept the
evidence as regards of particulate steroids. [45].
5.7. Unreliability of the ligamentum flavuum as a loss of resistance sign
Anatomical studies have shown the inconsistent presence of the ligamentum flavuum.
Ligamentum flavum resistance is an unreliable sign in the cervical spine and the first resistance
appreciated may be the dura or cord. [46] This means that intracord injection may easily occur
with interlaminar epidural steroid injections with Tuohy spinal needles using “loss of
resistance” techniques as the latter is an unreliable sign in these circumstances.
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5.8. Spinal haematomas and peri venous counter spread
Subdural, subarachnoid or intra-cord needle placements followed by injections of contrast,
local anesthetic or corticosteroid can produce spinal cord injury, paralysis and death.
The cervical venous plexus is predominantly lateral and ventral as opposed to the thoracic,
which is predominantly posterior. Epidural hematomas are usually upper thoracic and lateral
recess stenosis compounds the problem.
Lawsuits are rare when an epidural hematoma is diagnosed early and surgical decompression
is carried out expeditiously [47]. A second opinion consult should be obtained if the first
surgeon wishes to delay surgical treatment of an acute epidural hematoma though conserva‐
tive management has been described [48]
Peri-venous counter spread (PVCS) has been reported and occurs when epidural injection
leads to pressure building on one side which forces flow to the opposite side [49]. If fluid is
unable to escape the spinal canal, pressure can compress the cord and produce quadriplegia.
When recognized, the patient should flex and rotate the neck. Then causes the pars of the facet
joints to slide over one another and enlarge the neural foramina. This provides an escape route
for injected material and pressure release.
This procedure has become a standard of practice and is described in multiple publications. It
should be used to spread cervical injectate and allow lateral run-off.
When pressure builds up, the patient will complain of ipsilateral pain possibly spreading
bilaterally. Neck and arm pain precede chest pain and spinal cord ischemia. Numbness,
weakness and paralysis can be prevented by repetitive exercises.
PVCS has been described as a mechanism for acute compression, which may be relieved by
repetitive chin to shoulder flexion exercises. These movements increase the size of the cervical
canal, allowing spread of injectate and pressure reduction. Thoracic catheter placement and
advancement to the cervical level in the lateral epidural space may reduce the risk of com‐
partmental injection by opening lateral run off. The practice of avoiding the lateral epidural
space may predispose patients to loculation and syrinx formation.
We recommend caution or avoidance of epidural injections in patients with a syrinx, arnold
chiari malformations and arachnoiditis. Paralysis and other severe neurological complications
have been seen. [50, 51]. The only effective treatment for injecting the wrong contrast is
irrigation of cerebrospinal fluid with saline. Injections in patients with arachnoiditis is
hazardous because dissection can occur into the subdural space and loculation can occur
leading to circulatory compromise to the spinal cord.
5.9. Sub-occipital injections
Sub-occipital injections have been associated with the “locked in phenomenon”, brain stem
infarction and death. Injectate can tract retrograde along the occipital nerve and dissect into
the CNS.
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Sub-occipital decompression has not been associated with the “lock in” phenomenon. 10 cases
of complications with intraneural injection have occurred but not with the use of the Stealth
(Epimed, International) 20-gauge 2” needle aimed just below and slightly posterior to C1. The
“locked in” phenomenon, while rare, is an example of the importance of recognizing an
emergency and being able to respond with resuscitative measures.
5.10. Arachnoiditis
It is still not clear what causes arachnoiditis, though epidural injection of modern drugs are
unlikely to be associated with such a complication. In contrast intrathecal injection of steroids
has been associated with histological changes in animal studies and also probably humans [52]
[53]. Studies of epidural steroids and contrast suggest greater changes with the injection of
contrast media. [54]. Therefore contrast injection should be limited to agents, which are safe
for intrathecal use.
The cause of a recent report of urological problems and severe dense foot drop following a few
days post blind caudal injections for contralateral radicular pain is uncertain but infection has
been postulated for the arachnoiditis seen on imaging [55]. Recently, a 30 million dollar lawsuit
was brought after a patient developed arachnoiditis after multiple wet taps during attempted
spinal cord stimulator electrode placement. The allegation was that an epidural blood patch
caused the arachnoiditis. The medical records weighed 97 pounds and the trial lasted 2 weeks
but the defense prevailed. Nevertheless, it is not uncommon for the Tuohy type needle to enter
the subdural space without the physician recognizing it. Cerbrospinal fluid may not appear
during the procedure.
5.11. Radiofrequency of the medial branches
In principal radiofrequency of the medial branch seems to be an inherently safe procedure [56].
It is however important to warn patients about post operative soreness and inconsequential
long term numbness due to lesioning of the lateral branch [57]. Such procedures may have
poorer prognoses in those patients who appear to catastrophize and alternative treatment
offered, certainly initially [58], though subsequently such procedures can be beneficial to the
overall pain and psychological state [51, 59].
Radiofrequency procedure complications and medicolegal  cases  include instances  where
sharp  needles  enter  nerves  or  arteries  and  where  injection  created  pressure,  which  is
transmitted to  a  distant  structure.  Additionally,  thermocoagulation of  unintended struc‐
tures, such as the vagus nerve during a C2-3 facet denervation, can occur. Permanent losses
of voice and hoarseness have been complications. The vagus nerve courses slightly anterior
and  lateral  to  the  target  [60].  For  this  reason,  performing  bilateral  upper  cervical  facet
denervations at the same sitting is not advisable. Patients should be brought back for the
second side. In addition, weakness of cervical muscles can occur resulting in a permanent
inability to raise the head. [61]
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5.12. Complications of opioid therapy
The prescription of a strong opioids is a significant therapeutic which can be associated with
poor outcomes including overdose and death. It is important that the rational for such a
prescription is fully documented with informed consent [62].
Opioid rotation in the presence of benzodiazepines is associated with respiratory arrest.
Outpatient spinal opioid trials are as well. Many patients receive psychiatric care in secrecy to
avoid insurance premium increases. These patients may not disclose their complete medica‐
tion list and may be taking centrally acting drugs without the knowledge of the pain physician.
Urine drug testing may help to some degree but many drugs are not routinely tested. Opioid
rotation, at least at high does, should not be done in one stroke [63] [64]. One opioid can be
reduced while another one titrated.
Some centers now recommend benzodiazepine tapering before optimization/ rotation of
opioid therapy especially in the elderly.
Methadone, while inexpensive, is falling out of favor due to deaths associated with its use for
chronic pain [65]. Spinal opioid trials are best done as an inpatient [66] [67].
Many patients take herbal products and the pharmacologic effects of these products are
unknown but should be documented as there is growing evidence that they may interact with
more standard pharmaceutical agents.
6. Informed consent
Written informed consent should be obtained before any procedure to document education of
the patient regarding risks of the procedure and to fulfill the legal requirement and avoid a
charge of battery.
In Texas, new laws require specific language for informed consent for three types of pain
procedures.
6.1. Neuroaxial procedures (injections into or around spine)
Failure to reduce pain or worsening of pain
Nerve damage including paralysis (inability to move)
Epidural hematoma (bleeding in or around spinal canal)
Infection
Seizure
Persistent leak of spinal fluid, which may require surgery
Breathing and/or heart problems including cardiac arrest (heart stops beating)
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6.2. Peripheral and visceral nerve blocks and/or ablation
Failure to reduce pain or worsen pain
Bleeding
Nerve damage including paralysis (inability to move)
Infection
Damage to nearby organ or structure seizure
6.3. Implantation of pain control devices
Failure to reduce pain or worsening of pain
Nerve damage including paralysis (inability to move)
Epidural hematoma (bleeding in or around spinal cord)
Infection
Persistent leak of spinal fluid which may require surgery
6.4. Brief comments as regards serving as an expert witness
Before serving as an expert witness, one must feel comfortable holding themselves out as
experts. Many fine physicians are not experts and the expert must have a curriculum vitae and
enough experience to qualify as an expert in a court of law. Experts must limit their expert
opinion to their area of expertise. Being an expert in one area does not qualify one to be an
expert in a related by different area. Medical societies may expel members for testifying against
other members if the testimony is unprofessional.
Second, before committing to serve as an expert, the records should be reviewed. No conflict
of interest should exist between the expert and either party to a lawsuit. For example, one
should avoid defending or testifying against a business partner or a business competitor.
Testifying against another physician is a difficult task, as is, defending a doctor who has had
a serious complication. Each side will have compelling arguments and the expert must be
completely comfortable with the testimony they will give. While physicians are given consid‐
erable leeway to testify, the expert’s reputation is at stake as much as the defendant’s. The
expert should make certain that the attorney, who calls them to testify, is aware of what the
expert is willing to say and what the expert is not willing to say before any trial is scheduled.
Experts must be willing to make themselves available once they have committed to a case.
Court schedules change and delays are inevitable. Fees for serving as an expert should be in
a similar range with what the physician would generate during the same time in practice, plus
any expenses for travel, etc.
The medical legal aspects of pain management are unlikely to become less complex with time.
Physicians need to increase their activity in specialty societies and political action committees
in order to avoid the consequences of remaining silent.
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7. Summary
This chapter has been but a brief introduction to how to reduce complications and by taking
on board some of the messages in the chapter we hope you will not find a two or three period
of your life being dominated by litigation with your professional and personal integrity being
scrutinized in a harsh way.
Primum non nocere, or first do no harm is the maxim to follow. An awareness of the likely
scenarios for complications, recognizing both patient, disease and technique related factors
associated with such adverse outcomes and avoiding them can achieve a great deal in
continuing to both enjoy ones clinical practice and get a good night’s sleep.
We as the authors, intend to expand this chapter significantly in future years based on our
experience of having to deal with many such cases in the medicolegal setting. We wish you
well and invite you to share any cases with us that you might wish us to consider including
in future years, to inform and educate us all.
A summary of some potential complications of injection and other
therapies and how to avoid them
PROCEDURE COMPLICATION MECHANISM POTENTIAL
SOLUTION
Thoracic and cervical trigger
point injection
Pneumothorax 25-30 g needle
Fanning technique
22 g
Avoid fanning
Transforaminal Spinal cord or vertebral artery
injection
Sharp needle intravascular or
intraneral penetration
Use a blunt needle use
Single shot epidural steroid
injection
Subdural injection Dural laceration from sharp
touhy or spinal needle
Use of blunt needle e.g
RX 2 coude
Epidural needle palcement Intracord injection Initial loss of resistance is
deep to epidural space due
to inconsistant ligamentum
flavum at cervical levels
Entry level at t 2
Catheter placement to
cervical level :use
contrast
Occipital block- total spinal from injection in
foramen magnum, intra-arterial
injection and local anesthetic
toxicity, occipital nerve injury,
hematoma
Use of 20 gauge
stealth needle and
suboccipital
decompression
technique. Use of
contrast and avoid
large volumes
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PROCEDURE COMPLICATION MECHANISM POTENTIAL
SOLUTION
Cervical transforaminal steroid
injections
total spinal, vertebral artery
injury, cerebellar hemorrhage,
spinal cord infarct
Use of sharp needle Use of blunt coude
needle
Avoid particulate
steroid
Cervical interlaminar steroid
injections
spinal cord injury, epidural
hematoma, epidural abscess,
loculation of injectate
Use of sharp needle Use of blunt needle Rx
2 coude epidural
needle
Cervical sympathetic block total spinal, pneumothorax,
horner’s syndrome, recurrent
laryngeal nerve block, brachial
plexus block, intravascular
injection and seizure,
pneumochylothorax
Classic technique Use of C7 lateral body
technique blunt
needle with Bella D
needle
Atlanto occipital block ataxia Central local anesthetic effectMinimize local
anesthetic volume
Cervical 3 facet denervation Hoarseness Vagus nerve injury Avoid bilateral
procedure
Bilateral cervical injections Respiratory arrest Bilateral phrenic nerve
blockade
Avoid bilateral
procedure
Cervical facet injection total spinal, spinal cord injury Medial needle placement Frequent use of
Anterior posterior
flouroscopic
localization
Intercostal block pneumothorax Plural puncture with sharp
needle
Use of flouroscopy and
fixation of needle at
skin puncture site
Lumbar sympathetic block retroperitoneal hematoma,
lymphatic injury
Vascular structure puncture Use of blunt coude
needle
Lumbar transforaminal injection paraplegia Segmental Arterial injection Use of blunt coude
and avoid deep
foraminal placement
Avoid particulate
steroid
Lumbar sympathetic block
Hypogastric plexus block
impotence, bladder
dysfunction
Autonomic block Avoid bilateral
procedure
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